you're kidding, right? . . . the court case has progressed since june . . . glad you put down the bong, but . . .
are you it? . . . our best source for court info . . . when did you get the plaintiff info from?, tia . . .
and huge thanks for those of us too cheap to pay for pacer . . .
looks to me like Mr. Cross lost his attorney . . . i bet they could tell they would not be appointed lead and gave up . . .
pro hac filings are by attorneys who are not licensed in the jurisdiction, it's permission to plead without a local license . . .
on order 47 i could use some help, lol . . .
funny, the market crashed 1000 points, and we're still at 1.43 . . . poor shorty . . .
how's that JUNO treating ya'?,lol . . . don't worry, lots of other bagholders fell for that ruse too . . . are you learning yet?
future, UP YOUR GAME!!!
'cmon dude . . . everyone but you knows it's one CA, based on an AF hit piece, and the class has yet to be certified . . .
but do you really think babcock is the first in biotech to raise money through offerings? . . . is this your first biotech rebound company? . . . the key is to buy intrinsic value, courtesy of the shareholders who didn't have the patience to wait for the payday . . .
newbies can buy JUNO . . . still zero income, lots of PR . . . and they can ride it down to 1.50, where the SMART BIO INVESTORS scoop up the intrinsic value . . . compare ISR to JUNO in the key stats, lol . . .
learn the system . . . check JAZZ, EXAS, ACAD, LGND, ETC ETC ETC . . .
the street did put out a negative report with a sell rating last week, but AF didn't sign his name to it, lolololol . . . "the street staff" . . . with boiler plate reasons to sell . . . i don't know if itwas posted here yet . . .
IsoRay Inc - ISR - EQUITY
Reviewed By: TheStreet Ratings on July 30, 2015.
Report Summary: TheStreet Ratings team rates IsoRay Inc as a Sell with a ratings score of D.
Report Snippet: We rate ISORAY INC (ISR) a SELL. This is driven by a few notable weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its poor profit margins, weak operating cash flow and generally disappointing historical performance in the stock itself.
just the smarter rats, still less than one mil volume . . . 7.3 million rats on board . . .
there can be no other reason for low volume other than the constant bashing going on here on the yahoo message board . . . it proves that the top source for due diligence is anonymous posters at yahoo . . . who needs wall street, we have multiple john nelsons, lol . . .
i guess carry on, as long as you feel important, that's what counts . . .
adam, meet Roberts, Kaplan, and Watts, lol
. . . the team is ready to go . . . NO CLASS . . . 6 dumb traders who read a blog is NOT A CLASS . . . then countersue . . . if the class is certified, file a CROSS-COMPLAINT . . .
same link i used . . .
Case # 4:15-cv-05046
duffy v. isoray
it might be the 21st or the 27th . . . doc. 24 is the court order . . . i'm not payin', lol . . .
at babcock's request . . . sorry CA lawyers, go get that plane ticket . . .
For the convenience of parties and witnesses and in the interest of justice, the action is hereby transferred to the United States District Court for the Eastern District of Washington